{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:13:48Z","timestamp":1786986828277,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004572","name":"National Health and Family Planning Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["201402012"],"award-info":[{"award-number":["201402012"]}],"id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014173","name":"Health and Family Planning Commission of Shenzhen Municipality","doi-asserted-by":"crossref","award":["201506051"],"award-info":[{"award-number":["201506051"]}],"id":[{"id":"10.13039\/501100014173","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Municipal Government of China","award":["JCYJ20160429174400950"],"award-info":[{"award-number":["JCYJ20160429174400950"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM201812002"],"award-info":[{"award-number":["SZSM201812002"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clim.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T12:53:04Z","timestamp":1534769584000},"page":"60-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Identification of a novel de novo gain-of-function mutation of PIK3CD in a patient with activated phosphoinositide 3-kinase \u03b4 syndrome"],"prefix":"10.1016","volume":"197","author":[{"given":"Ying","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2018.08.007_bb0005","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.clim.2018.08.007_bb0010","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3389\/fimmu.2017.02005","article-title":"Epstein-Barr Virus Susceptibility in Activated PI3Kdelta Syndrome (APDS) Immunodeficiency","volume":"8","author":"Carpier","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0015","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00543","article-title":"Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase delta Syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase delta Syndrome Registry","volume":"9","author":"Maccari","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev-immunol-032712-095946","article-title":"Signaling by the phosphoinositide 3-kinase family in immune cells","volume":"31","author":"Okkenhaug","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0035","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood-2009-07-232330","article-title":"PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans","volume":"115","author":"Soond","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.08.007_bb0040","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1002\/jcp.26539","article-title":"Targeting the phosphatidylinositol 3-kinase\/Akt\/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: an update","volume":"233","author":"Simioni","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.clim.2018.08.007_bb0045","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2016.08.028","article-title":"Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD","volume":"139","author":"Dulau Florea","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2017.01.004","article-title":"Genetic defects in PI3Kdelta affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections","volume":"176","author":"Wentink","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0055","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1073\/pnas.1205305109","article-title":"Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasis","volume":"109","author":"Willinger","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.clim.2018.08.007_bb0060","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jaci.2016.03.055","article-title":"Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase delta syndrome-like immunodeficiency","volume":"138","author":"Tsujita","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0065","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.1617244114","article-title":"Conformational disruption of PI3K\u03b4 regulation by immunodeficiency mutations in PIK3CD and PIK3R1","volume":"114","author":"Dornan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2018.08.007_bb0070","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.str.2011.06.003","article-title":"Dynamics of the phosphoinositide 3-kinase p110delta interaction with p85alpha and membranes reveals aspects of regulation distinct from p110alpha","volume":"19","author":"Burke","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.clim.2018.08.007_bb0075","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1126\/science.1150799","article-title":"The structure of a human p110alpha\/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations","volume":"318","author":"Huang","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.clim.2018.08.007_bb0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10875-014-0012-9","article-title":"Mutations in PIK3CD can Cause Hyper IgM Syndrome (HIGM) Associated with increased Cancer Susceptibility","volume":"34","author":"Crank","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2017.05.020","article-title":"A novel germline gain-of-function variant in PIK3CD","volume":"181","author":"Rae","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0095","unstructured":"A.J. Takeda, Y. Zhang, G.L. Dornan, B.D. Siempelkamp, M.L. Jenkins, H.F. Matthews, J.J. McElwee, W. Bi, F.O. Seeborg, H.C. Su, J.E. Burke, C.L. Lucas, Novel PIK3CD mutations affecting N-terminal residues of p110delta cause activated PI3Kdelta syndrome (APDS) in humans, J. Allergy Clin. Immunol., 140 (2017) 1152\u20131156. (doi:10.1016\/j.jaci.2017.03.026)."},{"key":"10.1016\/j.clim.2018.08.007_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00575","article-title":"Molecular Mechanisms of Human Disease Mediated by Oncogenic and primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases","volume":"9","author":"Dornan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri.2016.93","article-title":"PI3Kdelta and primary immunodeficiencies","volume":"16","author":"Lucas","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0110","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1681\/ASN.2005050549","article-title":"Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats","volume":"17","author":"Lloberas","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2018.08.007_bb0115","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.4049\/jimmunol.1203094","article-title":"Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection","volume":"190","author":"Foldenauer","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0120","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.177.8.5122","article-title":"The p110 Isoform of Phosphoinositide 3-Kinase Controls Clonal expansion and Differentiation of Th Cells","volume":"177","author":"Okkenhaug","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/eji.200636401","article-title":"Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation","volume":"37","author":"Nashed","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2018.08.007_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/BST0350167","article-title":"The PI3K p110\u03b4 controls T-cell development, differentiation and regulation","volume":"35","author":"Patton","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.clim.2018.08.007_bb0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.celrep.2012.02.007","article-title":"PI3K-Akt-mTORC1-S6K1\/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma","volume":"1","author":"Kurebayashi","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2018.08.007_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146516","article-title":"Inhibition of Phosphoinositide 3-Kinase p110delta does not Affect T Cell Driven Development of Type 1 Diabetes despite significant Effects on Cytokine Production","volume":"11","author":"Barbera Betancourt","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2018.08.007_bb0145","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/imm.12096","article-title":"Sirolimus ameliorates inflammatory responses by switching the regulatory T\/T helper type 17 profile in murine colitis","volume":"139","author":"Yin","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2018.08.007_bb0150","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2018.08.007_bb0155","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617309178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617309178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T20:36:40Z","timestamp":1589920600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661617309178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":31,"alternative-id":["S1521661617309178"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.08.007","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel de novo gain-of-function mutation of PIK3CD in a patient with activated phosphoinositide 3-kinase \u03b4 syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}